Belumosudil Mesilate

5 trials 4 recruiting Orphan designation

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

4 Recruiting

1 Completed trials

3 Sponsors

16 Countries

Phase III

Phase II

Phase I/II

Phase III: 2 Phase II: 1 Phase I/II: 2

Oversight events:

13 temporary halts across 1 trial

View oversight register →

Indications tested

Chronic graft versus host disease 3 Plasma cell myeloma refractory 1 Lung transplant rejection 1

Sponsors using this IMP

Sanofi-Aventis Recherche & Developpement 3 Medical Center - University Of Freiburg 1 Sanofi-Aventis Research & Development 1

All trials

5 total

BEAT-GVHD (Belumosudil for acute/chronic GVHD overlap syndrome) Recruiting

2025-521940-39-00 Phase II 1 country Medical Center - University Of Freiburg
A study of belumosudil in children with chronic graft versus host disease (schoolROCK). Recruiting

2024-511508-18-00 Phase I/II 6 countries Sanofi-Aventis Recherche & Developpement
A study to test how effective belumosudil tablets are for treating adult participants with chronic lung allograft dysfunction Recruiting

2023-503462-23-00 Phase III 14 countries Sanofi-Aventis Recherche & Developpement
Isatuximab in combination with SAR445761 (belumosudil) and dexamethasone in relapsed or refractory multiple myeloma Recruiting

2024-514992-16-00 Phase I/II 6 countries Sanofi-Aventis Recherche & Developpement
A study to test an oral medicine, belumosudil, in combination with corticosteroids in participants at least 12 years of age with newly diagn… Ended

2023-505394-32-00 Phase III 13 countries Sanofi-Aventis Research & Development

Showing 1–5 of 5 trials

← All drugs A–Z